Medicare Broker for Macular Degeneration Patients — Coverage for Injections, Monitoring, and More

A Medicare broker for macular degeneration patients does one thing well: match you with coverage that actually fits your treatment. If you're getting eye injections every month or tracking dry AMD with regular scans, the wrong plan can cost you thousands.
I'm Anthony Orner, a licensed Medicare broker. I help AMD patients sort through Part B, Part D, Medigap, and Advantage options so nothing falls through the cracks. The call is free.
Call for Free Advice — 855-559-1700How Medicare Part B covers anti-VEGF eye injections
Part B covers anti-VEGF drugs like Avastin, Eylea, and Lucentis when your retina specialist administers them in-office. These are classified as Part B drugs, not Part D.
After your $283 annual Part B deductible (2026), you pay 20% of the Medicare-approved amount. That 20% adds up fast when Eylea runs over $1,850 per injection and you're going in monthly. A Medigap plan can cover that coinsurance completely.
Frequency of retinal exams and OCT scans under Medicare
Part B covers diagnostic OCT scans, fluorescein angiography, and visual acuity testing when your doctor orders them as medically necessary. For wet AMD patients, that often means imaging every 4 to 8 weeks.
Dry AMD patients typically see a retina specialist once or twice a year for monitoring. If your condition progresses, your doctor adjusts the schedule and Medicare follows.
Part D coverage for dry AMD supplements and prescriptions
AREDS2 vitamins are the standard recommendation for intermediate dry AMD. Since they're available over the counter, most Part D plans won't cover them. Budget roughly $25 to $40 a month out of pocket.
If your ophthalmologist prescribes other medications, Part D formularies vary by plan. I check your specific drugs against available plans to find the lowest total cost.
Why plan choice matters more with AMD
People dealing with macular degeneration often worry about two things: keeping their specialist and controlling costs if treatment escalates. Those are the right concerns.
- Original Medicare + Medigap: See any retina specialist who accepts Medicare. No referrals. Medigap covers the 20% coinsurance on injections.
- Medicare Advantage: May add routine eye exams and eyewear benefits, but can restrict which specialists you see and require prior authorization for treatments.
If your retina specialist is already managing your care, switching to a plan with a narrow network can disrupt treatment at the worst time.
The real cost concern nobody warns you about
Wet AMD treatment can mean 12 or more injections a year. At 20% coinsurance on a $1,850 drug, that's over $4,400 annually in out-of-pocket costs with Original Medicare alone. Avastin brings that down dramatically at roughly $50 per injection, but not every specialist uses it.
A Medigap Plan G or Plan N eliminates or reduces that exposure. I'll run the numbers based on your actual treatment frequency.
Get a free plan match for your macular degeneration care
You shouldn't have to figure out formularies, coinsurance math, and specialist networks while managing a condition that threatens your vision. That's what I do.
Call me at 855-559-1700 for a free, no-pressure plan comparison. I'll look at your doctors, your drugs, and your treatment schedule and show you what makes sense.
Talk to a broker who understands AMD coverage
Call 855-559-1700 or Get a Free Quote